Morning Briefing
Summaries of health policy coverage from major news organizations
First Edition: Thursday, Nov. 12, 2026
KFF HEALTH NEWS ORIGINAL STORIES
KFF Health News: Dubious Buys Raise Alarm Over Local Control Of Opioid Cash
State and local governments spent about $3.7 billion in opioid settlement funds last year. That’s more than the median annual income of 42,000 American families combined. The money comes from companies that were sued for aggressively pushing painkillers and fueling the opioid crisis. (Pattani, 11/12)
KFF Health News: Opioid Settlement Cash And Homelessness: It’s Not Always Clear How Addiction Fits In
Jason Fazekas has spent most of his adult life on the street or behind bars. He was addicted to heroin for decades and often stole to support his habit. On rainy days, he slept in building stairwells to stay dry. On winter mornings, he woke up with fingers too numb to bend. That all changed in September when he moved into a one-bedroom apartment in East Haven, Connecticut. (Pattani, 11/12)
KFF Health News: Listen To The Latest ‘KFF Health News Minute’
Sam Whitehead reads the week’s news: Your phone may know when you’re visiting the doctor, and companies are using that information to sell unproven treatments. Plus, more dads are taking time off to bond with their newborns through state leave programs. (11/12)
THE LATEST ELECTION RESULTS
AP: Mississippi Elects Democrat Scott Colom As State’s First Black US Senator Since Reconstruction
Democratic nominee Scott Colom defeated Republican Sen. Cindy Hyde-Smith on Wednesday in Mississippi’s closely contested U.S. Senate race after a prolonged ballot counting process, giving the state its first Black U.S. senator since post-Civil War Reconstruction. Colom’s narrow victory is a seismic shift in Mississippi, which has been controlled mostly by white conservatives for generations despite having the largest share of Black residents of any U.S. state. (Barrow and Bates, 11/12)
THE TRUMP ADMINISTRATION
Stat: Committee Vote Set For Heidi Overton, FDA Commissioner Nominee
The Senate health committee has scheduled a pivotal vote for next week on the nomination of Heidi Overton to serve as commissioner of the Food and Drug Administration — despite lingering doubts from Republicans on the panel. (Manto, 11/11)
Politico: Former FDA Head Accuses Trump Aides Of Bowing To Industry
Former FDA Commissioner Marty Makary on Tuesday backed up a former White House adviser’s criticisms about industry influence over the administration’s health care policies. “A lot of pressure from White House and HHS aides was not on medical cures or healthy food but instead on getting more vapes approved and catering to lobbyists,” Makary told POLITICO. “Americans don’t want their kids smoking strawberry banana vapes — they want a government that stands up to corruption.” (Gardner and Cai, 11/11)
AP: Millions May Lose Food Aid As Trump Administration Closes SNAP Loophole
President Donald Trump’s administration is planning to make it harder to get food aid through the federal government’s big grocery assistance program that serves about 1 in 10 Americans. The administration says the proposed rule would close a loophole by no longer allowing some people who receive benefits under the federal Temporary Assistance for Needy Families program to automatically qualify for the separate Supplemental Nutrition Assistance Program too. (Mulvihill and Lieb, 11/11)
Politico: Stephen Miller’s Appointment Energizes RFK Jr. And His MAHA Allies
Robert F. Kennedy Jr. and his Make America Healthy Again devotees are setting sky-high expectations for the White House now that Stephen Miller is running the show there. Since President Donald Trump named Miller to replace Susie Wiles as his chief of staff, Kennedy and his supporters have celebrated Miller as a steadfast ally. “Next to me, Stephen Miller is the strongest MAHA supporter in the administration,” Kennedy wrote on social media platform X on Friday. “It’s time to unleash the Kraken.” If Kennedy’s right, it would be quite the comeback. (Paun and Chu, 11/11)
Politico: Calley Means Accuses Susie Wiles Of Interfering In Hemp Policy
A former senior adviser to Health Secretary Robert F. Kennedy Jr. says Susie Wiles played a prominent role in steering the White House’s hemp policy stance — which has led to a delay for a pending ban on intoxicating hemp products. Calley Means has accused Wiles, the recently departed White House chief of staff, of doing industry’s bidding to help ultraprocessed food, e-cigarette and pesticide makers to the detriment of public health. He told POLITICO that the hemp pressure campaign is yet another example. (Friedman, 11/10)
The New York Times: A Beloved Nurse Was Arrested, Shackled And Hidden In ICE’s System
Ann Lawani, a highly regarded nurse and professor, was still in her pajamas when federal agents detained her at her home in Lodi, Calif., on Sept. 16. She placed a call that day to family from a nearby holding facility. After that, however, her siblings and lawyer could not find her in a public database that shows where detainees are being held. They got no answers from Immigration and Customs Enforcement. Ms. Lawani had simply vanished. (Jordan, 11/10)
ON CAPITOL HILL
AP: House Approves Bill To Boost Compensation For Many Veterans
The House passed a major package of veterans bills Wednesday on Veterans Day — but not without confusion and controversy. The centerpiece of the package is an effort to boost compensation for an estimated 58,000 veterans who are medically retired because of combat-related injuries. That objective has broad, bipartisan support in Congress, but lawmakers and veterans groups aren’t on the same page about how to get there. (Freking, 11/11)
The Hill: Sen. Rand Paul Seeks Leadership Role On Senate Health Committee
Sen. Rand Paul (R-Ky.) said Wednesday he is seeking the top GOP spot on the powerful Senate health committee next Congress, a move that would likely signal a major shift for the focus of Republicans on the panel. Paul, an ophthalmologist, is the most senior Republican on the panel. He is currently the chair of the Senate Homeland Security Committee but would give that up to move to the Committee on Health, Education, Labor and Pensions (HELP). (Weixel, 11/11)
The Hill: Democratic Senators Question RFK Jr Regarding $250,000 Worth Of Gifts From Former Donor
Two Democratic senators launched a probe into Health and Human Services Secretary (HHS) Robert F. Kennedy Jr. this week after financial reports revealed he received over $250,000 in gifts last year from a former donor to his presidential campaign. In a letter addressed to the HHS secretary on Tuesday, Sens. Angela Alsobrooks (Md.) and Robert Wyden (Ore.) requested Kennedy provide more information about these gifts. (Davis, 11/11)
MEASLES
The New York Times: The U.S. Has Lost Its Measles-Elimination Status, Data Suggests
Measles is once again endemic — a constant and predictable presence — in the United States, 26 years after it was declared eliminated in the country, an analysis of genetic data from outbreaks of the disease has found. Data from the outbreaks will be the focus of deliberations by an international panel of scientific experts convening on Tuesday to decide whether the United States should lose its official designation as a nation that has eliminated measles. An announcement of the decision is expected on Nov. 17. The New York Times asked several scientists to analyze the publicly available genetic data before the meeting. (Mandavilli, 11/10)
ABC News: Measles Cases Grow Among Pregnant Women In Pennsylvania: What To Know About Risks
Measles cases in Pennsylvania have now surpassed 1,500, according to data reported on Monday. As the outbreak continues to grow, doctors and health officials are concerned about a rising number of cases among pregnant women, posing a risk to both mom and baby. As of Nov. 6, "the Pennsylvania Department of Health (DOH) has now confirmed that 97 of the state's measles cases in 2026 were in pregnant women," Stephanie Nojiri, the DOH deputy press secretary, told ABC News. (Cobern, 11/10)
EBOLA OUTBREAK
The New York Times: Kenya Contains Ebola Outbreak As Last Patient Leaves Hospital
Kenya began a countdown on Wednesday to declare the end of its Ebola outbreak. The final patient who had tested positive for the virus was discharged from the hospital on Wednesday. And the Kenyan cabinet secretary for health, Aden Duale, said at a news conference that the last 11 people being monitored for Ebola symptoms had also been discharged after completing a 21-day quarantine period. (Bigg, 11/11)
Bloomberg: Kenya Rejects US Plan To Host Ebola Quarantine Facility For Travelers
Kenya said it won’t serve as a quarantine hub for travelers heading to other countries, an apparent reversal of plans to host a facility for US citizens exposed to the Ebola virus. “Travelers will not be detained in Kenya to fulfill entry requirements imposed by their destination countries,” the health ministry said in a statement following the discharge of its last known Ebola patient. “The ministry will not issue quarantine or Ebola-free certificates for travel purposes, as such requirements have no basis in the International Health Regulations.” (Nyambura, 11/11)
Bloomberg: Ebola Outbreak In Congo Tops 11,000 Cases As MSF Warns Of Response Failures
Ebola remains out of control in the Democratic Republic of Congo six months after the outbreak was declared, with frontline workers going unpaid and health facilities lacking basic supplies despite hundreds of millions of dollars mobilized for the response, a medical aid group said. “Despite the vast amounts of money provided for the response, many frontline responders are left trying to contain the outbreak with empty hands and empty pockets,” Javid Abdelmoneim, the international president of Médecins Sans Frontières, or Doctors Without Borders, said in a statement Thursday. (Gale, 11/12)
TRANSGENDER CARE
The Washington Post: Most Transgender People Have No Regrets Years After Hormone Therapy, Study Says
Most transgender people who receive hormone therapy as teenagers do not regret it, according to a study published Monday in JAMA Pediatrics. Researchers at University of Texas Southwestern Medical Center and other universities surveyed 376 transgender and gender-diverse people and found that five years after the initial treatment, 360, or nearly 97 percent, said starting hormone therapy was the right decision, and roughly 3 percent said they regretted taking the medication. Nearly 2 percent said they both regretted the transition and believe it harmed them. On average, the participants started hormone therapy at age 16. (Parks, 11/11)
The 19th: Lawsuit Quickly Follows Washington Ballot Measure On Trans Sports Participation
A coalition of parents, educators and nonprofit organizations sued the state of Washington late Monday over a recently passed ballot initiative banning transgender girls from competing on girls’ K-12 sports teams, arguing that the measure, which is set to take effect next month, conflicts with the state’s own constitution. (Migdon, 11/10)
The 19th: Republicans Bet Everything On Anti-Trans Messaging. It Didn’t Pay Off.
Florida Gov. Ron DeSantis, a Republican who has passed some of the most extreme anti-LGBTQ+ laws in the country, and Democratic Rep. Sarah McBride of Delaware, the first transgender member of Congress, don’t have much in common. But they do have a similar assessment of what drove Republicans’ historic losses in last week’s midterms. “Anti-trans politics was a flop this election,” McBride said on a Monday press call with the Human Rights Campaign, the country’s largest LGBTQ+ advocacy group. (Migdon and Rummler, 11/10)
HEALTHCARE INDUSTRY
MedPage Today: Last Batch Of New Residency Spots Doled Out By CMS
As the Centers for Medicare & Medicaid Services (CMS) doled out the final 200 of an additional 1,000 residency positions created by Congress 5 years ago, medical groups called for more federally funded spots to mitigate workforce shortages. (Fiore, 11/11)
STLPR: Illinois Health Department Preps To Move Patients From Granite City Hospital
Illinois regulators are preparing to potentially transfer patients out of Gateway Regional Medical Center in Granite City, and ambulances are being sent to other hospitals. The hospital is still open, but the Illinois Department of Public Health confirmed Gateway and another medical center owned by the same company are on bypass status due to “staffing instability.” (Fentem, 11/10)
Modern Healthcare: BJC Health Plans To Acquire St. Luke’s Hospital In St. Louis
BJC Health plans to acquire St. Luke’s Hospital in St. Louis, the nonprofit health system announced Wednesday. St. Louis-based BJC and St. Luke’s signed a letter of intent to combine, according to a news release. The organizations will work during the coming months on a definitive agreement and securing customary regulatory approvals. An expected closing date for the proposed transaction was not given. (Kacik, 11/11)
Cardinal News: Tie Vote Again Delays Advancement Of Plan To Close State-Run Long-Term Care Facility
Virginia lawmakers again delayed a vote Tuesday to advance plans to close Hiram Davis Medical Center, a state-run long-term care and skilled nursing facility in Petersburg. (Schabacker, 11/11)
WUSF: $47M Grant Aims To Make Moffitt A Hub For Radiopharmaceutical Cancer Treatment
A Tampa Bay coalition has landed $47.3 million in federal funding to help establish the region as a national hub for developing and manufacturing radiopharmaceuticals, an emerging field of cancer treatment that the United States is looking to expand domestically. (Mayer, 11/10)
Becker's Hospital Review: Lehigh Valley Hospital Sues Highmark Over Specialty Drug Access
The specialty pharmacy operated by Allentown, Pa.-based Lehigh Valley Health Network, under Philadelphia-based Jefferson Health, filed a lawsuit Nov. 10 against Highmark regarding the ability to dispense drugs. The complaint, filed in a state court, alleged that Highmark is blocking LVHN’s pharmacy from dispensing some high-cost, self-administered specialty drugs to Highmark members, including LVHN patients. According to the lawsuit, LVHN’s pharmacy is a participating provider under a Sept. 25, 2023, contract, but Highmark routes some prescriptions to other pharmacies, including Highmark Health’s Allegheny Health Network Specialty Pharmacy. (Casolo, 11/11)
Modern Healthcare: Hims & Hers FTC Lawsuit Expands As Five More States Join
Five states joined a Federal Trade Commission lawsuit alleging Hims & Hers shared patients’ sensitive health information with third-party advertising platforms and misled customers about its billing practices. The FTC first filed the suit in July with Utah and Los Angeles County. The amended complaint was filed in the U.S. District Court for the Northern District of California on Tuesday. It now includes Florida, Nebraska, Ohio, Arizona and Wisconsin. (Famakinwa, 11/11)
Cardinal News: Unnecessary Medical Tests Are Raising Healthcare Costs. A Group Of Virginia Doctors And Researchers Has Shown It's Possible To Change The Approach.
When a patient arrives in the doctor’s office with back pain, it’s become routine for some clinicians to immediately order an MRI, even when established guidelines don’t recommend imaging. A prescription for opioids to manage the pain often follows. According to a recent initiative by the Virginia Center for Health Innovation, similar patterns of unnecessary treatments have become ingrained across healthcare, driving up costs for patients and health systems. (Schabacker, 11/12)
The New York Times: Hospitals Brace For Medicaid Work Rules And Deep Funding Cuts
Hospitals across the country are mobilizing an expansive outreach effort in an attempt to ensure that roughly 19 million patients do not lose their insurance coverage under new Medicaid work rules that begin in January. Saying the requirements are generating widespread anxiety and confusion, health care executives are using a variety of methods to help guide the Americans who will be affected. They are deploying staff and volunteers to contact patients with text messages, phone calls and offers of help. (Rowland, 11/11)
PHARMA AND TECH
Healthcare Dive: Google Cloud Debuts Gemini For Healthcare
Google Cloud has launched Gemini for healthcare, a version of its AI agent designed to be used by providers and payers in clinical and administrative settings, the company announced on Tuesday. The platform connects to a healthcare organization’s electronic health record, claims workflows and other systems to automatically surface patient records, prep paperwork and check insurance details. Google is betting those integrations will reduce clinician burnout and promote interoperability, according to the announcement. (Hughes, 11/11)
CNBC: CANARX Official Arrested On Drug Importation Charges
U.S. authorities are accusing the two top officials of a Canadian company of operating a long-running scheme to illegally import prescription drugs into the U.S., according to court records filed Tuesday. (Zamost, 11/11)
The Washington Post: As Gene Editing For Deafness Advances, Gallaudet University Speaks Out
The world’s leading school for deaf and hard-of-hearing students took an official position on advancing therapies, saying, “Deaf lives are not deficits to be corrected.” (Solano, 11/11)
The New York Times: New Research Compares Long-Term Relief From 21 Antidepressants
A new meta-analysis found that certain antidepressants worked better on average than Prozac at helping people with depression feel better and stick with their treatment over the long term. The analysis looked at 21 different drugs across 115 studies to identify which drugs were most likely to help patients who planned to use antidepressants for more than three months. The study authors compared each drug to Prozac, also known as fluoxetine, because it’s a well-known drug that has been commonly prescribed, researchers said. (Caron, 11/10)
Fox News: New Weight-Loss Drug Offers Significant Relief From Chronic Knee Pain, Major Study Finds
An experimental weight-loss drug significantly reduced chronic knee pain and improved mobility in people with obesity and knee osteoarthritis, according to two clinical trials led by researchers at Northwestern University. The trials, which were funded by Eli Lilly and published in The New England Journal of Medicine, evaluated retatrutide, a once-weekly injectable medication developed by Eli Lilly and Co. (Quill, 11/11)
STATE WATCH
MPR News: Minnesota Medicaid Reimbursements Totaling More Than $112M Denied By Trump Administration
The federal Centers for Medicare and Medicaid Services has denied Minnesota more than $112 million in Medicaid reimbursements for the quarter ending Sept. 30, 2025, raising concerns about the potential impact on more than 1 million state residents who rely on the program. (Zurek, 11/10)
Maryland Matters: Maryland Health Panel Backs Insurer Tax, Drug Price Limits
A healthcare coverage watchdog group is urging lawmakers to free up funding to meet a “desperate need” for revenue to keep people insured. The Maryland Health Insurance Coverage Protection Commission recommended Tuesday that legislators extend a 1% tax on insurance carriers. They also backed legislation that would make it easier for state officials to lower certain prescription drug costs. (Brown, 11/11)
New Hampshire Public Radio: NH Lawmaker Proposes Bill To Classify Kratom As A Dangerous Drug, Similar To Heroin
A New Hampshire state senator has proposed a bill to classify kratom under the strictest level of drug controls, indicating it has a high potential for abuse. Sen. Bill Gannon, a Republican from Sandown, wants the state to classify kratom as a Schedule 1 drug. The U.S. Drug Enforcement Administration is also seeking to categorize synthetic kratom as a Schedule 1 drug, similar to heroin. (Tuohy, 11/11)
The Texas Tribune: Texas Could More Closely Review Abortion-Ban Deaths
With a power shift imminent at the Texas Capitol, advocates are more hopeful than ever that incoming elected officials will finally empower the state’s beleaguered maternal mortality committee to review abortion-related deaths. (Draeger-Mazer, 11/10)
North Carolina Health News: Period Poverty Bill Sought By HPU Students
High Point University senior Tatum James and three classmates spent about 10 minutes on Monday trying to convince former High Point Mayor Jay Wagner to support legislation forbidding states from taxing products to help women manage their menstrual cycles. (Fernandez, 11/12)
GLOBAL WATCH
The New York Times: The Russian Scientist Behind The Deadly Novichok Nerve Agents Has Died
Vladimir Uglev, a Russian chemist who during the Cold War developed a class of highly deadly nerve agents called Novichok, then turned against the Russian government when it was used against dissidents including Alexei A. Navalny, died on Oct. 25 in Anapa, Russia. He was 80. His son Alexandr confirmed the death, in a hospital, from complications of a heart attack. (Risen, 11/11)